MedPath

Reproductive health program for young wome

Not Applicable
Completed
Conditions
Reproductive health
Pregnancy and Childbirth
Registration Number
ISRCTN12556383
Lead Sponsor
Korea University
Brief Summary

2022 Results article in https://doi.org/10.1002/nop2.1425 (added 17/11/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
60
Inclusion Criteria

1. Young adult women aged between 18 and 25
2. Women who had coitus in the last 3 months and had partners

Phase 2 of the study:
3. Women in Stages 1, 2, and 3 of the PAPM for reproductive health via an online survey

Exclusion Criteria

Women in Stages 4, 5, and 6 of the PAPM for reproductive health

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Reproductive health-promoting behavior measured using self-reported questionnaire via online survey at T0 (baseline), T1(2 weeks after baseline), and T3 (after completion of intervention/8 weeks after baseline)<br>2. Rate of contraception use measured using self-reported questionnaire via online survey at T0, T3<br><br>Outcomes are measured at three timepoints: T0 indicates the baseline, T1 indicates 1 week after the seminar (2 weeks after baseline) and T2 indicates within 1 week after completion of the interventions (8 weeks after baseline).
Secondary Outcome Measures
NameTimeMethod
1. Reproductive health knowledge measured using self-reported questionnaire via online survey at T0, T1, T3<br>2. Reproductive health belief measured using self-reported questionnaire via online survey at T0, T1, T3<br>3. Reproductive health motivation measured using self-reported questionnaire via online survey at T0, T1, T3<br>4. Reproductive health self-efficacy measured using self-reported questionnaire via online survey at T0, T1, T3<br><br>Outcomes are measured at three timepoints: T0 indicates the baseline, T1 indicates 1 week after the seminar (2 weeks after baseline) and T2 indicates within 1 week after completion of the interventions (8 weeks after baseline).
© Copyright 2025. All Rights Reserved by MedPath